Comparison of Efficacy, Safety, and Tolerability of ITCA 650 to Empagliflozin and Glimepiride as add-on Metformin
Clinical trial NCT03060980 · TERMINATED
Trial details
- NCT number
- NCT03060980
- Sponsor
- Intarcia Therapeutics
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2017-03-03
- Primary completion
- 2018-01-26
- Enrollment
- 245
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.